07 March 2024
If a Foreign Subsidiary Company takes External Commercial Borrowings (ECBs) from its Holding Company at a lower interest rate compared to the prevailing industry rate. In this scenario: 1. Is this considered a compound financial instrument, requiring accounting treatment as per Ind AS 109? 2. If so, what benchmark rate should be used for valuation, especially when a comparable rate is unavailable? Further clarification: a) The company has prepared its financial statements in accordance with Ind AS for the first time (First-time Adoption of IND AS). b) The company has been in a loss-making position for the last 10-11 years. Therefore, the company is not in a position or eligible to take any borrowings from banks, financial institutions, or other non-related parties. So, what comparable rate should be used if Ind AS 109 is to be applied?
If any professionals or individuals have expertise or experience in handling this particular situation, please provide insights in the comments section below.
CAclubindia
